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Abstract
Background: Although the statement that age is the greatest risk factor for Age-related macular degeneration (AMD) is
widely accepted, the cellular and molecular explanations for that clinical statement are not generally known. A major focus
of AMD research is the retinal pigment epithelium (RPE)/choroid. The purpose of this study was to characterize the changes
in the RPE/choroid with age that may provide a background for the development of AMD.
Methodology/Principal Findings: We compared the transcriptional profiles, key protein levels and histology of the RPE/
choroid from young and old mice. Using three statistical methods, microarray data demonstrated marked changes in the
old mouse. There were 315 genes differentially expressed with age; most of these genes were related to immune responses
and inflammatory activity. Canonical pathways having significant numbers of upregulated genes in aged RPE/choroid
included leukocyte extravasation, complement cascades, natural killer cell signaling and IL-10 signaling. By contrast, the
adjacent neural retina showed completely different age-related changes. The levels of proteins that participate in leukocyte
extravasation and complement pathways were consistently increased in the normal, aged RPE/choroid. Furthermore, there
was increased gene expression and protein levels of leukocyte attracting signal, chemokine ligand 2 (Ccl2) in aged RPE/
choroid. In old animals, there was marked extravasation and accumulation of leukocytes from the choroidal circulation onto
Bruch’s membrane and into the RPE.
Conclusions/Significance: These phenotypic changes indicate that the RPE/choroid in the normal, old mouse has become
an immunologically active tissue. There are signals from the normal, aged RPE/choroid which recruit leukocytes from the
circulation and activate the complement cascade. These age-related changes that occur in the RPE/choroid with age, to the
extent that they occur in the human retina, may provide the background for an error in regulation of immunological activity
to cause AMD to appear in an elderly individual.
Citation: Chen H, Liu B, Lukas TJ, Neufeld AH (2008) The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related
Macular Degeneration. PLoS ONE 3(6): e2339. doi:10.1371/journal.pone.0002339
Editor: Karl-Wilhelm Koch, University of Oldenburg, Germany
Received March 31, 2008; Accepted April 24, 2008; Published June 4, 2008
Copyright:  2008 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by NIH grant EY12017, a generous gift from the Forsythe Foundation and an unrestricted grant from Research to Prevent
Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: a-neufeld@northwestern.edu
Introduction
Although the statement that age is a risk factor for many adult
human diseases is widely accepted, the cellular and molecular
explanations for that clinical statement are not generally known
[1,2]. We believe that older individuals have underlying changes in
specific tissues that increase the susceptibility of the tissues to
causative disease processes and/or contribute to progression of the
age-related disease. Thus, certain age-related changes can be
identified as susceptibility factors and may occasionally be
manifested clinically as risk factors. The key to identifying these
underlying factors is to characterize the phenotype of the normal,
aged tissue.
We hypothesize that normal aging of the retinal pigment
epithelium (RPE)/choroid provides a background for the devel-
opment of age-related macular degeneration (AMD). The RPE,
which is adjacent to the photoreceptors and rests on Bruch’s
membrane, phagocytoses and digests the distal parts of the outer
segments of the photoreceptors. The choroid, on the other side of
Bruch’s membrane, supplies oxygen and nutrients to the RPE and
photoreceptors. The early stage of dry AMD is characterized by
the presence of drusen in the macula between the RPE and
Bruch’s membrane. Drusen diminishes diffusion from the
choroidal circulation to the retina, causing adverse effects on both
the RPE and photoreceptors [3,4]. Many laboratories studying the
components of drusen have shown that drusen has a complex
protein composition that includes immunoglobulins, activated
complement components and complement regulators from the
choroidal circulation [4–6], and lipids, intracellular proteins and
cytosolic stress response proteins from RPE cells [6]. However, the
etiology of drusen and why the presence of drusen increases with
age are not completely understood.
AMD is likely to be a multi-factorial disease. Human genetic
studies have identified genes, e.g. ABCA4 [7], CX3CR1 [8],
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which are associated with AMD. Recently, variants of CFH
(complement factor H) [9,13], LOC387715/HTRA1 [14–16] and
BF/C2 (complement factor B/ complement component 2) [17,18]
have been highlighted as major loci contributing to AMD [19,20].
In human RPE/choroid, there are differentially expressed genes
related to inflammation in the macular region compared to
extramacular regions [21]. Whereas several genes are associated
with AMD and more are likely to be identified, the genetic findings
do not provide an explanation for the onset of AMD late in life.
To test our hypothesis that there are underlying changes in the
RPE/choroid with age that provide a background for the
development of AMD, we compared gene expression profiles,
key protein levels and cell markers in the RPE/choroid of young
and old mice. Our results indicate that in the old mouse, the RPE/
choroid has become an immunologically active tissue. We believe
that these marked differences with age in the RPE/choroid, if
similar changes occur in the human retina, contain the underlying
cellular and molecular activities for the development of AMD.
Results
Comparison of functional categories of altered gene
expression with age.
The microarray data from RPE/choroid have been deposited in
NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/) and are accessible through GEO Series accession
number GSE10965. By comparing RPE/choroid tissues from
young and old animals, the analyses of our microarray data
showed consistent results and distinctive transcriptional profiles.
There were 315 differentially expressed genes from the analysis
using Limma (Table S1), 300 from DNA-Chip Analyzer (Dchip)
and 309 from Significance Analysis of Microarrays (SAM). 227
genes were in common for the three analytical methods. To
identify the distinctive transcriptional profile, we performed
hierarchical clustering to analyze the 315 differentially expressed
genes from Limma analysis. A clustering map is shown in Figure 1
A, comparing the expression of 315 genes in the RPE/choroid
from young and old animals and clearly demonstrating marked
differences. Among the 315 genes, 33 genes were decreased and
282 genes were increased with age.
Global functional analyses and canonical pathway analyses
using Ingenuity Pathway Analysis of the 315 differentially
expressed genes (Limma) yielded distinct categories and pathways
related to immune responses and inflammatory activities. There
were 16 canonical pathways that were significantly upregulated in
aged RPE/choroid. The first 10 canonical pathways, ordered by
significance (Fig. 1 B) are: (1) leukocyte extravasation signaling; (2)
complement cascades; (3) natural killer (NK) cell signaling; (4) IL-
10 signaling; (5) B cell signaling; (6) T cell signaling; (7) IL-2
signaling; (8) GM-CSF (granulocyte monocyte colony stimulating
factor) signaling; (9) Fc Epsilon RI signaling; and (10) chemokine
signaling. Nearly all the differentially expressed genes in these
pathways were upregulated (Fig. 1 B). Using the 300 genes from
Dchip and the 309 genes from SAM showed the same canonical
pathways when analyzed using Ingenuity Pathway Analysis. We
interpreted these results to indicate that there were increased
immunological and inflammatory activities in the RPE/choroid of
old animals. By contrast, the adjacent neural retina showed
completely different age-related changes in its transcriptional
profile. Of the 9 canonical pathways that showed significant
changes in neural retina with age, most were related to stress
responses and apoptosis (Fig. 1 C), but no immunological or
inflammatory pathways were upregulated.
Confirmation of altered gene expression by PCR
To validate the microarray data, we performed quantitative
RT-PCR on 2–3 functionally important genes from each of the
first 5 significantly changed canonical pathways. RT-PCR
confirmed that all of the increased genes chosen from the
microarray results were significantly increased (Fig. 2 A).
Moreover, the fold changes of old vs. young gene expression
levels were consistent, comparing the microarray and RT-PCR
data (Fig. 2 B). Only one gene, IL1RN, showed a higher fold
increase using RT-PCR than predicted from microarray data
(12.9 fold vs. 3.2 fold).
Putative altered functional pathways with age
The pathway with changes of the highest significance was
leukocyte extravasation signaling (p,10
216). There were 24 genes
in this pathway that significantly changed in the aged RPE/
choroid by Limma analysis and almost all showed significant
changes by Dchip and SAM analyses (Table 1; Fig. 1 B and 2 A).
Expression of 23 genes was increased, suggesting high leukocyte
extravasation activity in the RPE/choroid of old animals. The
upregulated genes are involved in leukocyte rolling and docking on
endothelial surfaces of capillaries and leukocyte transmigration
through capillary endothelial layers (Fig. 3). Several membrane
receptors that are crucial for interaction between leukocytes and
endothelial cells and for enhancing leukocytes recruitment [22–25]
showed significantly increased expression in the RPE/choroid of
old animals, including: ITGAM (aM-integrin), ITGB2 (b2-
integrin), ITGAL (aL-integrin) and ICAM1 (intercellular adhesion
molecule 1). In addition, expression of matrix metallproteases, that
are important effectors of inflammatory processes and also
essential for leukocyte extravasation and migration [26,27], was
also significantly increased, notably: MMP3 (matrix metallopro-
tease 3) and MMP13 (matrix metalloprotease 13).
Gene expression of members of the complement cascades was
upregulated (p,10
28) (Table 1; Fig. 1 B and 2 A) in the RPE/
choroid of old animals. Nine genes in the complement cascades
increased significantly with age (Fig. 4). Most of these genes are
involved in activation of either the classical complement pathway
or the alternative complement pathway, e.g. C1q (complement
component 1, q subcomponent, A chain, B chain and C chain),
C1r (complement component 1, r subcomponent), C3 (comple-
ment component 3) and C4 (complement component 4). The gene
expression data suggests the presence of complement pathway
activators in the aged RPE/choroid. Notably, the expression level
of C3 in the RPE/choroid from old animals was 9.4 fold of that in
young tissue.
Ten genes involved in NK cell signaling showed increased
expression in aged RPE/choroid (p,10
26) (Table 1; Fig. 1 B and
2 A; Fig. S1). There was increased expression of receptors and
their tyrosine kinase related proteins, which mediate the activation
of NK cell [28], including FCER1G (Fc fragment of IgE receptor),
FCGR3A (Fc fragment of IgG receptor), DAP12 (TYRO protein
tyrosine kinase binding protein) and LCK (lymphocyte-specific
protein tyrosine kinase). The common effector for these receptors,
SYK (spleen tyrosine kinase) and its several downstream
molecules, SH3BP2 (SH3-domain binding protein 2), VAV1
(vav 1 oncogene) and RAC2 (rho family, small GTP binding
protein Rac2), which are centrally involved in the transduction of
signals from immune receptors [29], also showed significantly
increased expression.
Interestingly, the RPE/choroid from old animals was also
associated with increased expression of genes that negatively
regulate inflammatory responses, notably IL-10 signaling
(p,10
25) (Table 1; Fig. 1 B and 2 A; Fig. S2). Expression of
Aged Retina Pigment Epithelium
PLoS ONE | www.plosone.org 2 June 2008 | Volume 3 | Issue 6 | e2339seven members in this pathway were increased with age, including
the membrane receptor IL10RA (IL-10 receptora), CCR1
(chemokine receptor 1), FCGR2 (Fc fragment of IgG receptor)
and HMOX1 (heme oxygenase 1).
Activation of leukocyte extravasation pathway in the
aged RPE/choroid
The most significant changes in gene expression were in
leukocyte extravasation pathways in the aged RPE/choroid. We
also found changes in the levels of proteins that participate in
extravasation of leukocytes in aged RPE/choroid. Consistent with
the gene expression, immunoblots demonstrated ICAM1 and
ITGB2, key molecules for the interaction between endothelial cells
and leukocytes, and leukocyte common antigen CD45, the
leukocyte marker, increased significantly in RPE/choroid from
old animals (Fig. 5 A).
Our interpretation of the gene expression and protein profiles is
that the aged RPE/choroid has become immunologically active.
Based on the upregulation of the genes and proteins of the
leukocyte extravasation signaling pathway, we predicted that we
should find leukocytes in the RPE/choroid from normal, old
Figure 1. Changes in gene expression in RPE/choroid from old animals. (A) The transcriptional profiles of the normal RPE/choroid from
young and old mice were analyzed by hierarchical clustering of 315 differentially expressed, age-regulated genes by Limma analysis. Standardized
expression values of genes are displayed according to the color scale, in which red represents above average expression and green represents below
average expression. Absolute fold changes of individual genes are shown in Table S1 online. (B) Relative changes in canonical pathways in RPE/
choroid from old animals. The upper figure shows the –log (p value) of the first 10 canonical pathways which changed significantly in RPE/choroid
from old animals. The horizontal line represents the threshold of p which is equivalent to p=0.05. Bars above the line indicate p,0.05. The lower part
of the figure shows the number of differentially expressed genes in each pathway. (C) The –log (p value) of the 9 canonical pathways which changed
significantly in neural retina from old animals.
doi:10.1371/journal.pone.0002339.g001
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determined the presence of leukocytes in the RPE/choroid by
using CD45, which recognizes all leukocytes including granulo-
cytes, lymphocytes and macrophages.
The immunofluorescent labeling for leukocytes showed that
there were marked differences between RPE/choroid tissue from
young and old animals (Fig. 5 B–I). In the young tissue, there were
no leukocytes attached to Bruch’s membrane or in the RPE (Fig. 5
B). In contrast, in the RPE/choroid from old animals, there were
many leukocytes attached to Bruch’s membrane (Fig. 5 C–E).
Some leukocytes attached to the endothelial surface of the
choroidal capillaries (Fig. 5 F), some leukocytes migrated from
the vessels to the local tissue (Fig. 5 G), and some leukocytes were
passing through Bruch’s membrane (Fig. 5 H). Thus, the RPE/
choroid in old animals has been invaded by leukocytes. These
findings suggest an active recruitment of leukocytes from the
choroidal circulation by the normal, aged RPE.
Activation of complement pathway in the aged RPE/
choroid
Based on the upregulated genes in the complement pathway in
aged RPE/choroid, we determined the levels of two important
activator proteins in aged RPE/choroid. C1 is the initial activator
of the classical complement pathway, and C3 is the activator of the
alternative pathway and the common pathway. Immunoblots
showed the protein level of C1q, one of the components of C1, and
C3, were increased in the aged tissue (Fig. 6 A), indicating the
complement pathway was activated in the normal, aged RPE/
choroid.
Immunofluorescent labeling showed there was C3 deposition on
Bruch’s membrane in both young and old animals, but with
different deposit patterns. In young animals, C3 presented as a
thin and continuous line associated with Bruch’s membrane (Fig. 6
B). However, in old animals, C3 deposition showed large and
discontinuous clumps on Bruch’s membrane (Fig. 6 C–E), which
was consistent with the increased amount of C3 in aged RPE/
choroid. The discontinuous deposition of C3 may imply that the
aged Bruch’s membrane might be damaged and fractured. These
findings suggested that the complement pathway was activated in
the normal, aged RPE/choroid.
Identifying the leukocyte attracting signal released from
the aged RPE/choroid
The above results suggested that there were signals from the
aged RPE/choroid which recruited leukocytes from the circula-
tion. Chemokine (C-C motif) ligand 2 (Ccl2) is a potent
chemotactic factor which attracts multiple leukocyte populations,
including monocytes, basophils, NK cells, T lymphocytes,
dendritic cells and neutrophils [30]. Our microarray data showed
Ccl2 was 1.6-fold increased in aged RPE/choroid (p,10
26). Real-
time PCR confirmed that the gene expression of Ccl2 was
significantly increased in aged RPE/choroid (Fig. 7 A; p,0.01,
n=4) with a higher fold change of 7.8. Immunoblot also showed
that the protein level of Ccl2 was significantly increased in the
aged RPE/choroid compared to tissue from young animals (Fig. 7
B; p,0.01, n=3).
Immunofluorescent labeling showed there was some weak
labeling for Ccl2 in the young RPE/choroid but Ccl2 labeling was
greatly increased in the aged RPE/choroid. In the aged RPE/
choroid, Ccl2 was present in RPE cells and endothelial cells (Fig. 7
C–F). Ccl2 may be one of the signals released from the normal,
aged RPE to attract leukocytes from the circulation. Real-time
PCR showed no significant difference for the gene expression of
chemokine (C-C motif) receptor 2 (Ccr2), the primary receptor for
Ccl2, between young and old (data not shown).
Discussion
There are phenotypic changes that occur in the neural retina and
in the RPE/choroid under normal aging conditions. Our findings
put into context human genetic studies demonstrating gene
mutations associated with AMD and animal models that exhibit
AMD like changes. Our results using comprehensive microarray
analyses, RT-PCR, immunoblots and immunofluorescent labeling
demonstrate that there are phenotypic changes in the aged RPE/
choroid that are associated with immune response effectors and
pathways.Thedifferencesinthegene expression profilescomparing
RPE/choroid and the adjacent neural retina from old animals are
striking. We interpret our results to indicate that the RPE/choroid
in the normal, old mouse has become an immunologically active
tissue. This interpretation is consistent with a report on limited
microarray data using aged RPE/choroid [31].
Figure 2. Real time RT-PCR confirmation of microarray results. (A) Relative mRNA expression levels of selected genes from the first 5
canonical pathways (see Fig. 1B) in RPE/choroid from young and old animals. (B) Comparison of the fold changes of the same selected genes
determined by microarray analysis and real-time RT-PCR. LES, leukocyte extravasation signaling; CC, complement cascade; NKCS, natural killer cell
signaling; ILS, IL-10 signaling; BCRS, B cell receptor signaling.
doi:10.1371/journal.pone.0002339.g002
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Name Description Gene Bank Fold Change p value No.
Leukocyte Extravasation Signaling
CXCR4 chemokine (C-X-C motif) receptor 4 D87747 2.9 0.000242 3
CYBA cytochrome b-245, alpha polypeptide AK018713 2.3 5.79E-05 3
CYBB cytochrome b-245, beta polypeptide AV373944 2.9 3.30E-05 3
ICAM1 intercellular adhesion molecule 1 (CD54) BC008626 2.1 6.26E-05 3
ITGAL integrin, alpha L (antigen CD11A (p180) BI554446 2.6 0.00041451 3
ITGAM integrin, alpha M (complement component 3 receptort) NM_008401 3.4 0.00017275 3
ITGB2 integrin, beta 2 (complement component 3 receptor) NM_008404 3.2 8.51E-05 3
MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) NM_010809 12.2 1.85E-05 3
MMP12 matrix metallopeptidase 12 (macrophage elastase) BC019135 2.1 0.001043 3
MMP13 matrix metallopeptidase 13 (collagenase 3) NM_008607 9.1 0.00031966 3
MMP19 matrix metallopeptidase 19 NM_021412 2.4 0.0034653 3
NCF1 neutrophil cytosolic factor 1 AI844633 2.5 6.61E-05 3
NCF2 neutrophil cytosolic factor 2 NM_010877 2.1 0.00073191 2
NCF4 neutrophil cytosolic factor 4 NM_008677 2.6 0.00037003 3
PIK3R5 phosphoinositide-3-kinase, regulatory subunit 5 AV230647 3.0 0.00031618 3
PTK2B PTK2B protein tyrosine kinase 2 beta NM_172498 2.1 0.00013604 3
RAC2 rho family, small GTP binding protein Rac2 NM_009008 2.4 0.00020253 3
RASSF5 Ras association (RalGDS/AF-6) domain family 5 NM_018750 2.1 0.00058134 3
THY1 Thy-1 cell surface antigen NM_009382 2.1 0.00023721 2
TIMP1 TIMP metallopeptidase inhibitor 1 BC008107 2.3 0.00039729 3
TIMP4 TIMP metallopeptidase inhibitor 4 BI788452 3.8 3.32E-05 3
VAV1 vav 1 oncogene NM_011691 2.6 5.35E-05 3
VCAM1 vascular cell adhesion molecule 1 L08431 2.5 5.04E-05 3
CLDN5 claudin 5 NM_013805 22.1 0.0041074 1
Complement Cascades
C3 complement component 3 K02782 9.4 3.47E-05 3
C1QA complement component 1, q subcomponent, A chain NM_007572 2.3 6.61E-05 3
C1QB complement component 1, q subcomponent, B chain NM_009777 2.6 5.24E-05 3
C1QC complement component 1, q subcomponent, C chain NM_007574 2.9 5.84E-05 3
C1R complement component 1, r subcomponent NM_023143 2.5 9.70E-06 3
C1S complement component 1, s subcomponent BC022123 2.4 5.24E-05 3
C3AR1 complement component 3a receptor 1 NM_009779 2.1 6.61E-05 3
C4B complement component 4B NM_009780 2.3 6.49E-05 3
CFB complement factor B NM_008198 2.2 3.73E-05 1
PLAUR plasminogen activator, urokinase receptor NM_011113 2.4 0.0055312 2
NK cell Signaling
CER1G Fc fragment of IgE, high affinity I, receptor for NM_010185 2.4 3.30E-05 3
FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a) BC027310 2.7 0.0014469 3
LAIR1 leukocyte-associated immunoglobulin-like receptor 1 AV370380? 3.5 0.00030431 3
LCK lymphocyte-specific protein tyrosine kinase NM_010693 2.2 0.00045097 2
PIK3R5 phosphoinositide-3-kinase, regulatory subunit 5, p101 AV230647 3.0 0.00031618 3
RAC2 rho family, small GTP binding protein Rac2 NM_009008 2.4 0.00020253 3
H3BP2 SH3-domain binding protein 2 BC010198 2.6 0.00024365 3
SYK spleen tyrosine kinase AW907526 2.4 0.00012293 3
YROBP TYRO protein tyrosine kinase binding protein NM_011662 2.3 3.30E-05 3
VAV1 vav 1 oncogene NM_011691 2.6 5.35E-05 3
IL-10 Signaling
ARG2 arginase, type II NM_009705 2.0 0.0039292 1
CCR1 chemokine (C-C motif) receptor 1 AV231648 2.9 0.00083896 3
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genes and proteins that participate in leukocyte extravasation. The
immunofluorescent labeling of abundant leukocytes, which may
include macrophages, lymphocytes and granulocytes, attaching to
Bruch’s membrane in the old animals extends our gene expression
and protein profiles to suggest functionality. These leukocytes may
be recruited into the local tissue for removing cellular waste
products or suppressing some activity in the normal aging process.
The accumulation of leukocytes at Bruch’s membrane and RPE
suggests that there are signals from the aged RPE/choroid which
recruit leukocytes from the circulation. From our data, the
increased gene expression and protein production of Ccl2, but not
Ccr2, in the aged RPE/choroid provides evidence in support of
Ccl2 being one of those signals. This result is consistent with the
Figure 3. Pathway diagram showing the molecules involved in leukocyte extravasation signaling and their interaction. Color nodes:
genes that changed significantly in RPE/choroid from old animals with a fold change .2. Red: upregulation; green: downregulation. The diagram was
modified from Ingenuity Pathway Analysis (IngenuityH Systems).
doi:10.1371/journal.pone.0002339.g003
Name Description Gene Bank Fold Change p value No.
CGR2B Fc fragment of IgG, low affinity IIb, receptor (CD32) BM224327 3.3 5.79E-05 3
FCGR3 Fc fragment of IgG, low affinity III NM_010188 2.5 0.00024334 3
HMOX1 heme oxygenase (decycling) 1 NM_010442 2.4 0.00071255 2
IL10RA interleukin 10 receptor, alpha NM_008348 2.6 6.15E-05 3
IL1RN interleukin 1 receptor antagonist M57525 3.4 6.61E-05 3
Shown are the differentially expressed genes in the 4 most significantly changed pathways in aged RPE/choroid by Limma analysis. Fold changes compare old vs.
young. ‘‘No.’’ means the number of statistical methods (Limma, Dchip and SAM) in which each gene appeared changed. See Table S1 online for a complete list of gene
expression changes in the RPE/choroid of old animals.
doi:10.1371/journal.pone.0002339.t001
Table 1. Cont.
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an increase in macrophages in the aged RPE/choroid of wild type
animals and that Ccl2
2/2 or Ccr2
2/2 mice, which have a defect
in macrophage recruitment, exhibit the principal hallmarks of
AMD after 16 months of age. Ccl2 appears to be an important
leukocyte attracting signal released from the RPE/choroid of old
animals.
Genetic studies have identified mutations in CFH, the negative
regulator of the complement cascade, as a gene responsible for
AMD [33–36]. CFH inhibits the alternative complement cascade
and also regulates the common pathway by inactivating C3b. Also,
recent findings have demonstrated the association of AMD with
two other complement genes, BF and C2, which are positive
regulators of the complement cascade [17]. CFH, C3b/iC3b and
BF have been colocalized in drusen and Bruch’s membrane,
suggesting these components of the complement pathway
participate in drusen formation [17,37]. A recent study showed
an increased membrane attack complex (C5b-9) in Bruch’s
membrane of normal, aged human retina [38]. In addition,
knockout of CFH in mice causes AMD-like changes when the
animals age [39]. Our findings in the normal aged RPE/choroid
fit well with these previous observations. For example, our
microarray data have a consistent finding of increased gene
expression of complement pathway genes, especially C3. The
protein levels of complement cascade activators, C1q and C3, are
increased in the aged RPE/choroid. Increased C3 protein is
present as clumps of deposits on Bruch’s membrane in old eyes. All
of these results suggest that the complement cascade is activated in
the RPE/choroid of old animals. We extrapolate our findings to
predict that an error in the complement pathway will not cause
AMD until the age-related changes leading to increased
immunological activity appear in the elderly adult.
Figure 4. Pathway diagram showing the molecules involved in complement pathway and their interaction. The diagram was modified
from Ingenuity Pathway Analysis (IngenuityH Systems).
doi:10.1371/journal.pone.0002339.g004
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macrophages and generate anti-inflammatory responses [40].
Several studies have demonstrated that interleukins (IL) including
IL-6, -8, and -10 are associated with AMD [41–43]. Our data
show several genes in IL-10 signaling are upregulated. Whether
the activation of IL-10 signaling is triggered directly by the aged
RPE/choroid or is a feedback response from the increased
immunological activity of the aged RPE/choroid is not known.
Figure 5. Active leukocytes recruitment in aged RPE/choroid. (A) Comparison of protein levels of ICAM1, ITGB2 and CD45 in RPE/choroid of
young (Y, n=3) and old (O, n=3) mice by immunoblot. ICAM1, ITGB2 and CD45 are all increased in RPE/choroids from old animals. b-actin was used
as a loading control. (B–I) Localization of leukocytes in young and old RPE/choroid. Leukocytes are labeled with leukocyte common antigen, CD45
(red). (B) In the young RPE/choroid, there are no leukocytes attached to Bruch’s membrane or in the RPE layer. (C–I) Leukocytes in the old RPE/
choroid. There are many leukocytes attached to Bruch’s membrane in the RPE/choroid in old animals (C–E, arrows). Note the leukocyte that is
attaching to the endothelial surface of the choroidal capillary (F, arrow heads), the leukocyte that migrated from the vessel to the local tissue (G,
arrow heads), and the leukocyte passing through Bruch’s membrane (H, arrow heads). The leukocyte attaching to Bruch’s membrane has a lobated
nucleus, indicating a polymorphonuclear leukocyte (I, arrow heads). OS, outer segment; RPE, retinal pigment epithelium; CC, choroidal capillaries; BM,
Bruch’s membrane. Scale bar=20 mm.
doi:10.1371/journal.pone.0002339.g005
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pathway regulation in the RPE/choroid of old animals suggests
that a balanced mechanism is crucial for this tissue to age properly.
We hypothesize that the aged RPE/choroid has become
intensely immunologically active and synthesizes proteins that
attract leukocytes and activate the complement pathway. Activa-
tion of these pathways, which are part of normal aging in the
RPE/choroid, requires extremely tight control by an intricate
series of activating and regulatory proteins. To the extent that
these age-related activities occur in the human RPE/choroid, any
dysfunction of this normal aging process, e.g. through defects in
BF, C2 or CFH, may predispose the aged RPE/choroid to AMD.
In humans, small differences in genomic DNA among individuals
can produce a spectrum of influences on immunological activities.
Polymorphisms, mutations or single nucleotide polymorphisms
(SNPs), which lead to changes of the normal immunological
activities in the aged RPE/choroid, have the potential of being
disease causing factors or susceptibility factors for the development
of AMD. We hypothesize that phenotypic changes in the aged,
human RPE/choroid provides the background for an error in
regulation of immunological activity to cause AMD to appear in
an elderly individual.
Materials and Methods
Mice
All protocols were in compliance with NIH guidelines and
approved by the Center for Comparative Medicine Committee at
Northwestern University. C57BL/6 male mice, 4 mos (young) and
26 mos (old) of age (NIA, Bethesda, MD) were used. Animals were
housed under standard conditions.
RNA Isolation
Mice neural retina and RPE/choroid were separated and
placed in RNA lysis buffer and RNA was extracted by using the
RNeasy Minikit (Qiagen). There were 12 neural retina and 8
RPE/choroid samples for microarray. Integrity and concentration
of RNA was evaluated using an Agilent 2100 Bioanalyzer (Agilent
Technologies).
Microarray analysis
The labeling and hybridization of the cRNA was performed at
the Functional Genomics Facility at The University of Chicago.
The cRNA were prepared following the Affymetrix GeneChip
Expression Analysis Manual. 12 mg of labeled cRNA were
Figure 6. Activation of complement pathway in RPE/choroid of old animals. (A) Comparison of protein levels of C1q and C3 in RPE/choroid
of young (Y, n=3) and old (O, n=3) mice by immunoblot. Both C1q and C3 are increased in aged RPE/choroids. b-actin was used as a loading control.
(B–E) C3 deposition (red) in RPE/choroids. (B) C3 staining shows a thin and continuous line at Bruch’s membrane in young animals (arrows). (C–E) In
old animals, C3 deposition shows large and discontinuous clumps at Bruch’s membrane (arrows). Scale bar=50 mm (B–D) or 20 mm (E).
doi:10.1371/journal.pone.0002339.g006
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and 60 rpm in an Affymetrix Hybridization Oven 640. The arrays
were washed and stained with streptavidin phycoerythrin in
Affymetrix Fluidics Station 450 following Affymetrix GeneChip
protocol and then scanned using an Affymetrix GeneChip
Scanner 3000.
Microarray data statistical analysis
The acquisition and initial quantification of array images were
performed using the GCOS (GeneChip Operating Software,
Affymetrix). The*.CEL files were obtained from GCOS.
We used three different methods to identify the differentially
expressed genes. We first used packages in Bioconductor [44] for
data analysis. The data were preprocessed and normalized using
the RMA method in affy package [45]. To reduce false positives,
we removed the probe-sets with all samples as ‘‘Absent’’ in the
data analysis. The probe-set ‘‘Present’’/‘‘Absent’’ calls were
estimated using the Wilcoxon signed rank-based algorithm [46]
implemented in affy package. Then we identified the differentially
expressed gene list by the empirical Bayes shrinkage moderated t-
statistics in Limma Bioconductor package [47]. We considered the
genes with fold-change .2.0 and false discovery rate (FDR) [48]
adjusted p,0.01 as significantly differentially expressed. The
second method we used was Dchip [49]. Invariant set normali-
zation was performed using Dchip2006 and perfect match-only
model was used for generating gene signal intensities. Genes that
met the criteria fold change .2 and statistical difference p,0.05
simultaneously were considered as significant changes. The third
method was SAM [50]. Microarray analysis was done with the
SAM module within BRB-Array tools (Version 3.4, NCI). Genes
were first filtered in BRB array tools to exclude genes where less
than 20% of the expression data had a 1.5-fold change in either
direction and where the missing or filtered out data exceeded 50%.
After this filtering, 1451 genes were submitted for SAM analysis.
The criterion for selection was a 1% FDR with 90% percentile
confidence.
Figure 7. Increase of Ccl2 in RPE/choroid of old animals. (A) Comparison of Ccl2 gene expression in RPE/choroid between young and old mice.
The expression level of Ccl2 is significantly increased in aged RPE/choroid (*p,0.01, n=4). (B) Comparison of protein levels of Ccl2 in RPE/choroid of
young (Y, n=3) and old (O, n=3) mice by immunoblot. Ccl2 is increased in aged RPE/choroids. Densitometric measurements confirm a significant
increase in Ccl2 protein level in aged RPE/choroid (*p,0.01, n=3). (C–F) Ccl2 distribution in RPE/choroid. Ccl2 is expressed in RPE cells (arrows) and
endothelial cells (arrowheads). There is weak labeling for Ccl2 in the young RPE/choroid (C, E); and the amount of Ccl2 appears increased in old
animals, especially in the choroid (D, F). Scale bar=50 mm.
doi:10.1371/journal.pone.0002339.g007
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identified differentially expressed genes were further analyzed for
global functional analyses, network analyses and canonical
pathway analyses using Ingenuity Pathway Analysis (IngenuityH
Systems, www.ingenuity.com). A differentially expressed gene list
containing gene identifiers and corresponding fold changes was
uploaded as an Excel spreadsheet into the software. Each gene
identifier was mapped to its corresponding gene object in the
Ingenuity Pathways Knowledge Base. We also used GOstats
Bioconductor package[44] for the Gene Ontology (GO) analysis.
Real-time RT-PCR
100 ng of total RNA (400 ng of total RNA for Ccl2 gene) from
each sample was reverse transcribed into cDNA using iScript
cDNA Synthesis Kit (Bio-Rad) and used as a template for real-
time PCR reactions. Specific primers (Table 2) were synthesized
by Integrated DNA Technologies. The RT-PCR reactions were
performed using iCycler (Bio-Rad). All samples were tested in
triplicate PCR reactions and the mean of the reactions was used
for calculating the expression levels. Expression levels were
normalized to 18S mRNA and analyzed by a standard two-tailed
t-test using GraphPad Prism (GraphPad Software, Inc).
Immunoblot analysis
The RPE/choroid was lysed in extraction buffer containing
50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA plus
protease inhibitors and phosphatase inhibitors (Pierce) and
sonicated for 5 sec before protein concentration determination
by the Bradford colorimetric assay. 20 mg proteins (40 mg of RPE/
choroid protein for Ccl2 detection) were loaded onto 4–12% SDS-
PAGE gels and electrotransferred on polyvinylidene fluoride
(PVDF) membranes (Amersham). The membrane was blocked for
1 hr at room temperature in blocking solution containing 5%
nonfat milk and 0.05% Tween 20 in Tris-buffered saline (TBS)
(25 mM Tris-HCl and 150 mM NaCl) and then incubated with
primary antibodies in blocking solution at 4uC overnight. The
following primary antibodies were used: goat anti-ICAM1 (1:200;
Santa Cruz), rat anti-ITGB2 (1:100; Santa Cruz), mouse anti-
CD45 (1:1000; BD Biosciences), rat anti-C1q (1:100, HyCult
biotechnology), rabbit anti-C3 (1:100; abcam), rabbit anti-Ccl2
(1:1000; abcam) and mouse anti-b-actin (1:20,000; Sigma).The
membrane was rinsed with 0.05% Tween 20 in TBS and
incubated with peroxidase-conjugated donkey anti-goat IgG
(1:15,000; Santa Cruz), goat anti-rat IgG (1:10,000), goat anti-
mouse IgG (1:10,000) or donkey anti-rabbit IgG (1:15,000) for
1 hr at room temperature. Finally, the blots were developed by
enhanced chemiluminescence (ECL) (Pierce) on Hyperfilm
(Amersham). The immunoblots for Ccl2 were scanned and
relative band density was determined using ImageJ (National
Institutes of Health, Bethesda, MD). The densities were normal-
ized to b-actin and analyzed by a standard two-tailed t-test using
GraphPad Prism.
Immunofluorescent labeling
Eyes were fixed in 4% paraformaldehyde in PBS for 4 hrs and
embedded in paraffin. 5 mm thick sections were de-waxed and
rehydrated. For antigen retrieval, the sections were heated in
10 mM sodium citrate buffer (pH 6.0) at a sub boiling temper-
ature for 10 min followed by cooling for 30 min. The tissue
sections were incubated with mouse anti-CD45 (1:200), rabbit
anti-C3 (1:100) or rabbit anti-Ccl2 (1:100; Chemicon) diluted in
5% BSA in PBS for overnight at 4uC. After several washes, tissue
sections were incubated with the secondary antibody, Alexa Fluor
568 goat anti-mouse IgG or donkey anti-rabbit IgG (1:800;
Molecular Probes) for 1 hr at room temperature. After washing
with PBS, slides were mounted with Vectorshield containing DAPI
(Vector Laboratory) and observed using fluorescence microscopy.
Supporting Information
Table S1 Genes that are differentially expressed with age in the
RPE/choroid
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NK cell signaling and their interaction. The diagram was modified
from Ingenuity Pathway Analysis (IngenuityH Systems).
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Figure S2 Pathway diagram showing the molecules involved in
IL-10 signaling and their interaction. The diagram was modified
from Ingenuity Pathway Analysis (IngenuityH Systems).
Found at: doi:10.1371/journal.pone.0002339.s003 (9.74 MB TIF)
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